All In Biotech

Investigational drug · Phase 2

Nab-placlitaxel

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers.

Phase 2

Last checked: Nov 20, 2026Latest source record: Jun 30, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

1

1 still active

All registered trials

1

Any phase or sponsor naming "Nab-placlitaxel"

First trial start

2024

Aug 26, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Nab-placlitaxel", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Locally Advanced Breast Cancer
  • Triple Negative Breast Cancer
  • Metastatic Triple Negative Breast Cancers

Approved drugs for the same conditions: Breast cancer · Oncology

Largest trials

Live from ClinicalTrials.gov: studies naming "Nab-placlitaxel" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Locally Advanced Breast Cancer

  • DB-1303BNT323, trastuzumab pamirtecanPhase 35 trials

    DualityBio Inc. · Metastatic Breast Cancer, HER2-positive Advanced Solid Tumor, Endometrial Cancer

  • PalazestrantOP-1250Phase 32 trials

    Olema Oncology, Inc. · Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer

  • Fixed of PertuzumabPhase 31 trial

    Roche (Genentech) · Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer

  • RPH-051Phase 31 trial

    R-Pharm · Locally Advanced Breast Cancer, Metastatic Breast Cancer

  • SamuraciclibICEC0942, CT7001Phase 23 trials

    Carrick Therapeutics Limited · Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer

  • FWD1802Phase 22 trials

    Forward Pharmaceuticals Co., Ltd. · Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage IV

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.